1
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
Condition(s):Cervical Cancer; Endometrial CancerLast Updated:May 12, 2023Not yet recruiting
Endometrial Neoplasms, AREA[OverallStatus], Open or Pending: 369 Clinical Trials, Page 1 of 37
Include Studies Not Open or Pending
2
Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial
Condition(s):Endometrial NeoplasmsLast Updated:April 4, 2023Recruiting
3
An Observational Study Based on Endometrial Cancer Risk Screening Model
Condition(s):Endometrial NeoplasmsLast Updated:December 2, 2022Recruiting
4
The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study
Condition(s):Endometrial NeoplasmsLast Updated:November 21, 2022Not yet recruiting
5
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
Condition(s):Endometrial NeoplasmsLast Updated:December 15, 2022Recruiting
6
Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
Condition(s):Endometrial NeoplasmsLast Updated:November 7, 2022Recruiting
7
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
Condition(s):Endometrial NeoplasmsLast Updated:June 7, 2023Recruiting
8
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Condition(s):Endometrial Neoplasm Malignant Stage ILast Updated:March 28, 2023Recruiting
9
Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study
Condition(s):Endometrial Neoplasms; Inflammatory ResponseLast Updated:December 20, 2022Recruiting
10
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)
Condition(s):Endometrial Neoplasms; Endometrial CancerLast Updated:April 3, 2023Not yet recruiting